8. Adverse reactions to medicines including contrast media Flashcards
what is an adverse event or experience
untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment
what is an adverse drug reaction
in the preapproval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic doses may not be established and all noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reaction
what is an unexpected adverse drug reaction
an adverse reaction the nature or severity of which is not consistent with the applicable product info
what does the term severe indicate
describes the intensity of a specific event, the event itself may be of relatively minor medical significance
eg severe headache
what does the term serious indicate
not the same as severe, which is based on patient even outcome or action criteria usually associated with events that pose a threat to a patients life or functioning
a serious adverse event/experience or reaction is any untoward medical occurrence that at any dose is what 6 things
results in death
life threatening
requires hospitalization/prolonged hospitalisation
results in persistent/significant disability
is a congenital anomaly/birth defect
is medically important event/reaction
what are mild severity graded adverse events in regard to how bad the symptoms are, how it is observed and what intervention is indicated
symptomatic/mild symptoms
clinical/diagnostic observation only
intervention not indicated
what are moderate severity graded adverse events in regard to what intervention is indicated and what activities are limited
minimal, local or non invasive intervention indicated
limiting age dependent daily living
what are severe/medically significant but not immediately life threatening severity graded adverse events in regard to outcomes
hospitalisation or prolongation of hospitalisation, disabling
what are the 5 common terminology criteria for adverse events severity grades
- mild
- moderate
- severe or medically significant but not immediately life threatening
- life threatening consequences
- death
how are adverse reactions graded in NZ
by letters A-I with A being the least severe and I being error causing death
what is category A adverse reaction
circumstances or events that have the capacity to cause error
what is category B adverse reaction
error occurred but error did not reach the patient
what is category C adverse reaction
error occurred that reached the patient but did not cause patient harm
what is category D adverse reaction
error occurred that reached the patient and required monitoring to confirm that it resulted in no harm to the patient and/or required intervention to preclude harm
the ADR mechanism involve what 2 things
interaction with receptor/enzymes (pharmacological?)
alteration of structural proteins, DNA or lipids (chemical)
what are type 1 or A adverse reactions
predictable dose dependent based on the known pharmacology of the drug
what are type 2 or B adverse reactions
not predictable, no clear dose dependency and not due to the known pharmacology of drug
type 1 or A adverse reactions happen due to what
due to the known pharmacology of the drug and are therefore dose dependent and predictable
what are 3 example situations of type 1/A adverse reaction causes
take too much drug (eg wrong dose/freq/duration)
take 2+ drugs with overlapping pharmacology
take 2+ drugs that have metabolic interaction
what do 2 or more drugs compete for in terms of absorption
reduced uptake, decreased effect
what do 2 or more drugs compete for in terms of metabolism in terms of clearance, inhibition, bioactivation, enzymes
reduced clearance = increased plasma conc
inhibition of one pathway = greater clearance via bioactivation = incr toxicity
induction of enzymes = decr plasma conc
what do 2 or more drugs compete for in terms of distribution
competition for uptake transporters or protein binding = increased plasma conc
what do 2 or more drugs compete for in terms of excretion
competition for efflux transporters = decreased elimination = increased plasma conc
what is a perpertrator drug and victim drug
perpetrator drug can inhibit the enzyme that metabolizes victim drug
this increases drug conc of victim drug
what happens when drug A induces the enzyme responsible for the metabolism of Drug B
plasma conc of drug B is less than expected = less activity = therapeutic failure
what is polypharmacy
taking several medicines at the same time (4 or 5+)
what is hyperpolypharmacy
10 or more medicines